Showing results (81-90 of 242) with videos related to
Sort By:
Pageof 25
Nature Communications|September 3, 2016
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancersMandar Deepak Muzumdar, Kimberly Judith Dorans, Katherine Minjee Chung, et al.Cancer Cell|January 22, 2011
Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progressionMichel DuPage, Ann F Cheung, Claire Mazumdar, et al.Nature Cell Biology|November 29, 2011
Single-molecule transcript counting of stem-cell markers in the mouse intestineShalev Itzkovitz, Anna Lyubimova, Irene C Blat, et al.Proceedings of the National Academy of Sciences of the United States of America|September 27, 2005
Use of gene expression profiling to direct in vivo molecular imaging of lung cancerJan Grimm, David G Kirsch, Stephen D Windsor, et al.Cancer Research|March 3, 2006
Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancerTakiko Daikoku, Susanne Tranguch, Irina N Trofimova, et al.Molecular and Cellular Biology|July 16, 2003
Rb and N-ras function together to control differentiation in the mouseChiaki Takahashi, Roderick T Bronson, Merav Socolovsky, et al.Cancer Cell|April 20, 2005
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 familyElsa R Flores, Shomit Sengupta, John B Miller, et al.Cell|December 21, 2004
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndromeKenneth P Olive, David A Tuveson, Zachary C Ruhe, et al.JCI Insight|May 8, 2026
Clonal hematopoiesis in lung adenocarcinoma pathogenesisTiziana Parisi, Blanca Santibanez Ocampo, Jacob Adelman, et al.Research Square|April 2, 2024
The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapiesEric Sweet-Cordero, Kieren Marini, Emma Champion, et al.Pageof 25